Next Allergy Blockbuster? GI Innovation Shares Why It Is Confident
CEO Aims For Korean Commercialization Model
GI Innovation chairman and CEO B G Rhee talks about his ambitions for the Korean bispecific protein firm’s leading allergy and immuno-oncology pipeline assets and what is behind his confidence.
